Hotta, Ryo
Rahman, Ahmed
Bhave, Sukhada
Stavely, Rhian
Pan, Weikang
Srinivasan, Shriya
de Couto, Geoffrey
Rodriguez-Borlado, Luis
Myers, Richard
Burns, Alan J.
Goldstein, Allan M.
Funding for this research was provided by:
Takeda Pharmaceuticals U.S.A.
Article History
Received: 27 June 2023
Accepted: 22 August 2023
First Online: 4 September 2023
Declarations
:
: This study was reviewed and approved by the Institutional Animal Care and Use Committee at Massachusetts General Hospital (Protocol #2009N000239, “Impact of aganglionosis on intestinal homeostasis in mouse models of Hirschsprung’s disease” on 8/12/2021). All methods were carried out in accordance with relevant guidelines and regulations. The reporting in the manuscript follows the recommendations in the ARRIVE guidelines.
: Not applicable.
: G.C., L.R.B., R.M., and A.J.B. are employees of Takeda Development Center Americas and hold stock and/or stock options in Takeda. R.H., A.R., S.B., R.S., W.P., S.S., and A.M.G. do not possess any competing interests.